These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9636479)

  • 21. Tolerability of mycophenolate mofetil in organ transplant recipients.
    Schweizer RT; Meisterling LD
    Transplant Proc; 2001 May; 33(3):2309. PubMed ID: 11377540
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients.
    Aigrain EJ; Shaghaghi EK; Baudouin V; Popon M; Loirat C
    Transplant Proc; 2000 Mar; 32(2):388-90. PubMed ID: 10715449
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate: better value through monitoring?
    Tredger JM; Brown NW
    Transplantation; 2006 Feb; 81(4):507-8. PubMed ID: 16495794
    [No Abstract]   [Full Text] [Related]  

  • 24. High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.
    Engelbertink R; Smak Gregoor P; Hesse C; IJzermans J; Weimar W; van Gelder T
    Transplant Proc; 2002 Nov; 34(7):2983-4. PubMed ID: 12431677
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of mycophenolic acid level: comparison of high-performance liquid chromatography with homogeneous enzyme-immunoassay.
    Yeung JS; Wang W; Chan L
    Transplant Proc; 1999; 31(1-2):1214-5. PubMed ID: 10083542
    [No Abstract]   [Full Text] [Related]  

  • 26. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
    Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
    Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
    [No Abstract]   [Full Text] [Related]  

  • 27. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
    Nicholls AJ
    Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetic study of mycophenolate mofetil in Asian renal transplant recipients.
    Yeung S; Tong KL; Tsang WK; Chan HW; Chan AY
    Transplant Proc; 2000 Nov; 32(7):1753-4. PubMed ID: 11119920
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of mycophenolic acid after renal transplantation.
    Wollenberg K; Krumme B; Schollmeyer P; Kirste G
    Transplant Proc; 1998 Aug; 30(5):2237-9. PubMed ID: 9723455
    [No Abstract]   [Full Text] [Related]  

  • 30. Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.
    Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
    Transplant Proc; 1997; 29(1-2):334-6. PubMed ID: 9123027
    [No Abstract]   [Full Text] [Related]  

  • 31. Monitoring of mycophenolic acid in pediatric renal transplant recipients.
    Armstrong VW; Shipkova M; Schütz E; Weber L; Tönshoff B; Oellerich M;
    Transplant Proc; 2001; 33(1-2):1040-3. PubMed ID: 11267182
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring of mycophenolic acid can be used as predictor of clinical events for kidney transplant recipients treated with mycophenolate mofetil.
    Lu YP; Zhu YC; Liang MZ; Nan F; Yu Q; Wang L; Wang J; Li YP
    Transplant Proc; 2006 Sep; 38(7):2048-50. PubMed ID: 16979995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved high-performance liquid chromatographic assay for the measurement of mycophenolic acid in human plasma.
    Li S; Yatscoff RW
    Transplant Proc; 1996 Apr; 28(2):938-40. PubMed ID: 8623471
    [No Abstract]   [Full Text] [Related]  

  • 35. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay.
    Shipkova M; Schütz E; Besenthal I; Fraunberger P; Wieland E
    Ther Drug Monit; 2010 Feb; 32(1):79-85. PubMed ID: 20042920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of renal graft function on mycophenolic acid pharmacokinetics during the early period after kidney transplant.
    Mohammadpur AH; Nazemian F; Abtahi B; Naghibi M
    Exp Clin Transplant; 2008 Dec; 6(4):276-81. PubMed ID: 19338489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: from principles to practice.
    Vathsala A; Lu YM
    Transplant Proc; 2001; 33(7-8):3137-9. PubMed ID: 11750348
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of mycophenolate mofetil in heart transplant recipients.
    Seebacher G; Mallinger R; Laufer G; Grimm M; Griesmacher A; Weigel G; Wolner E; Müller MM
    Adv Exp Med Biol; 1998; 431():801-3. PubMed ID: 9598174
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
    Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
    Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.